IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fairmount Funds Management LLC

Q3 2020 Holdings

Filed 2020-11-12 | 17 holdings | $55.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$26.7M647,83348.0%
Axsome Therapeutics Inc(AXSM)COM05464T104$15.7M220,09828.2%
Argenx SE(ARGX)SPONSORED ADR04016X101$13.1M49,95023.5%
Insmed Inc(INSM)COM PAR $.01457669307$34.0K1,056,7970.1%
Trillium Therapeutics IncCOM NEW89620X506$22.1K1,558,1810.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$20.6K1,455,3950.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$19.7K596,8900.0%
Zogenix IncCOM NEW98978L204$19.0K1,056,8750.0%
Unum Therapeutics IncCOM903214104$13.7K6,235,9030.0%
Allakos Inc(ALLKGUSD)COM01671P100$13.4K164,6620.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$10.3K702,3510.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$7.4K162,2360.0%
Amarin Corp PLCSPONS ADR NEW023111206$6.4K1,508,2370.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$5.8K35,0000.0%
Neoleukin Therapeutics IncCOM64049K104$4.5K372,7480.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$3.3K212,7460.0%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$624100,0000.0%